Trellus Health (LSE:TRLS) Other Stockholders Equity: £-1.64 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Trellus Health Other Stockholders Equity?

Trellus Health LSE:TRLS Other Stockholders Equity is £-1.64 Mil as of Jun. 2025. The stock has 2 warning signs investors should review.

Trellus Health's Other Stockholders Equity for the quarter that ended in Jun. 2025 was £-1.64 Mil.

Trellus Health's quarterly Other Stockholders Equity increased from Jun. 2024 (£-1.74 Mil) to Dec. 2024 (£-1.71 Mil) and increased from Dec. 2024 (£-1.71 Mil) to Jun. 2025 (£-1.64 Mil).

Trellus Health's annual Other Stockholders Equity increased from Dec. 2022 (£-2.43 Mil) to Dec. 2023 (£-1.75 Mil) and increased from Dec. 2023 (£-1.75 Mil) to Dec. 2024 (£-1.71 Mil).

Trellus Health Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Trellus Health's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trellus Health Other Stockholders Equity Chart

Trellus Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
0.00 -1.19 -2.43 -1.75 -1.71

Trellus Health Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.67 -1.75 -1.74 -1.71 -1.64

Trellus Health Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of £-1.64 Mil mean?
Trellus Health (LSE:TRLS) has a Other Stockholders Equity of £-1.64 Mil as of Jun. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Trellus Health and its competitors.
Is Trellus Health's Other Stockholders Equity too high?
Trellus Health's current Other Stockholders Equity is £-1.64 Mil.
How does Trellus Health's Other Stockholders Equity compare to VEEV and BTSG?
Trellus Health's Other Stockholders Equity of £-1.64 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Trellus Health and its competitors. Trellus Health's current Other Stockholders Equity is £-1.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current Other Stockholders Equity of £-1.64 Mil. The current Other Stockholders Equity is £-1.64 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current Other Stockholders Equity is £-1.64 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Trellus Health Business Description

Other Exchanges 85Q:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.